We’re thrilled to announce the Myeloma Investment Fund has announced a new investment in Envisagenics, an A.I.-driven biotechnology company. This partnership aims to advance RNA-based therapeutics, addressing critical unmet needs in multiple myeloma treatment. For more details, visit: https://lnkd.in/eKB7hVQn
Multiple Myeloma Research Foundation - MMRF
Non-profit Organizations
Norwalk, Connecticut 14,112 followers
Accelerating a smarter, faster, cure for mutiple myeloma.
About us
We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives. Central to our mission is our commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue. Since our inception, the MMRF has committed over $500 million for research, opened nearly 100 clinical trials, and helped bring 15+ FDA-approved therapies to market, which have tripled the life expectancy of myeloma patients.
- Website
-
http://themmrf.org
External link for Multiple Myeloma Research Foundation - MMRF
- Industry
- Non-profit Organizations
- Company size
- 51-200 employees
- Headquarters
- Norwalk, Connecticut
- Type
- Nonprofit
- Founded
- 1998
Locations
-
Primary
383 Main Avenue
5th Floor
Norwalk, Connecticut 06851, US
Employees at Multiple Myeloma Research Foundation - MMRF
-
Pam Lewis
Leader in Fundraising, Patient Advocacy and Programming. Catalyst and Pied Piper.
-
Christopher Williams
-
Adriana Davis
Producer/Editor/Voice-Over Artist, Director
-
Lori Tauber Marcus
Experienced Board Director, Chair, Compensation Committee, Nominating Governance Committee, Audit Committee, Board Development Committee, Public…
Updates
-
Healthcare professionals: Advance your knowledge and skills in managing bispecific antibody-associated adverse events. In our NEW #Myeloma Matters podcast episode, Dr. Jesus Berdeja, other experts, and patients share their perspectives on bispecific antibody therapy. Listen here: https://ow.ly/Pu3z50SKgm6
Myeloma Matters: Prevention and Management of Bispecific Antibody–Associated Adverse Events in Multiple Myeloma
reachmd.com
-
In each podcast episode, fellow #myeloma patients share their experiences and perspectives on important topics, including: 🎧 Bone Health 🎧 Immunotherapy Side Effects 🎧 Maintenance Therapy 🎧 ASCT 🎧 Newly Diagnosed Multiple Myeloma 🎧 & more! Listen now: https://ow.ly/ujpW50SKfS3
-
-
Health care professionals: In this roundtable, experts discuss the diagnosis of multiple #myeloma in primary care. A quick and accurate diagnosis is paramount. Earn your CME credit today: https://ow.ly/TtkF50SGh35
Multiple Myeloma and its Precursors in Primary Care | myCME
mycme.com
-
We’re here for you every day, week, and month ❤️. We offer educational resources and 1:1 support that help you along every step of your multiple myeloma journey. To find the support you need today, visit: https://ow.ly/1h4K50SGexi
-
-
Whether you're newly diagnosed, well into your treatment plan, or in remission, we have a series of booklets developed to answer your questions and guide you along your #myeloma journey. Download the MMRF Patient Toolkit today: https://ow.ly/kyQg50SzVst
-
-
🔬Cures Within Reach has a funding opportunity for clinical repurposing trials targeting any blood cancer, with a preference for trials impacting multiple myeloma and/or myelodysplastic syndromes. Learn more here: https://bit.ly/cwrrfps 💰 Budgets of up to $75,000 are accepted 📅 LOI due by 7/29/2024
Funding Opportunities / RFPs - Cures Within Reach
-
Today is #WorldEmojiDay! 🌎👏 These are the top emojis we have used so far this year to spread awareness about a rare and serious blood cancer, multiple #myeloma.
-
-
Multiple #myeloma is a blood cancer that develops in plasma cells in the bone marrow. Those 180,000 people are friends, family, and neighbors. Let’s come together to accelerate a cure for our community. Your donation can change lives❣️ Give today: https://ow.ly/oPHk50SzUO8
-
-
We are deeply saddened to share that we have lost one of our most beloved friends, Jack Aiello, this past weekend. Jack was not only a cherished member of our community but also one of our original Myeloma Mentors, a leader at our San Francisco Walk/Run, and a dedicated patient advocate. His passion, strength, and commitment to helping others will be profoundly missed. Our thoughts and condolences go out to his family and loved ones during this difficult time. It is because of patients like Jack that we continue to work relentlessly to advance new treatments for myeloma patients, and ultimately a cure.
-